BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 1662814)

  • 1. Transactivation of heterologous promoters by HIV-1 tat.
    Han P; Brown R; Barsoum J
    Nucleic Acids Res; 1991 Dec; 19(25):7225-9. PubMed ID: 1662814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
    Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
    J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
    Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
    Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 Tat protein can transactivate a heterologous TATAA element independent of viral promoter sequences and the trans-activation response element.
    Roebuck KA; Rabbi MF; Kagnoff MF
    AIDS; 1997 Feb; 11(2):139-46. PubMed ID: 9030359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exon2 of HIV-2 Tat contributes to transactivation of the HIV-2 LTR by increasing binding affinity to HIV-2 TAR RNA.
    Rhim H; Rice AP
    Nucleic Acids Res; 1994 Oct; 22(21):4405-13. PubMed ID: 7971271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription.
    Bieniasz PD; Grdina TA; Bogerd HP; Cullen BR
    Proc Natl Acad Sci U S A; 1999 Jul; 96(14):7791-6. PubMed ID: 10393900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Tat-mediated transactivation of HIV-1 LTR transcription by polyamide nucleic acid targeted to TAR hairpin element.
    Mayhood T; Kaushik N; Pandey PK; Kashanchi F; Deng L; Pandey VN
    Biochemistry; 2000 Sep; 39(38):11532-9. PubMed ID: 10995220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tat functions to stimulate the elongation properties of transcription complexes paused by the duplicated TAR RNA element of human immunodeficiency virus 2.
    García-Martínez LF; Mavankal G; Peters P; Wu-Baer F; Gaynor RB
    J Mol Biol; 1995 Dec; 254(3):350-63. PubMed ID: 7490754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA transcripts of the human immunodeficiency virus transactivation response element can inhibit action of the viral transactivator.
    Graham GJ; Maio JJ
    Proc Natl Acad Sci U S A; 1990 Aug; 87(15):5817-21. PubMed ID: 1696012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency viruses containing heterologous enhancer/promoters are replication competent and exhibit different lymphocyte tropisms.
    Chang LJ; McNulty E; Martin M
    J Virol; 1993 Feb; 67(2):743-52. PubMed ID: 8419644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. tat regulates binding of the human immunodeficiency virus trans-activating region RNA loop-binding protein TRP-185.
    Wu F; Garcia J; Sigman D; Gaynor R
    Genes Dev; 1991 Nov; 5(11):2128-40. PubMed ID: 1936997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TAR and Sp1-independent transactivation of HIV long terminal repeat by the Tat protein in the presence of human cytomegalovirus IE1/IE2.
    Dal Monte P; Landini MP; Sinclair J; Virelizier JL; Michelson S
    AIDS; 1997 Mar; 11(3):297-303. PubMed ID: 9147420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
    Beauparlant P; Kwon H; Clarke M; Lin R; Sonenberg N; Wainberg M; Hiscott J
    J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence.
    Tiley LS; Madore SJ; Malim MH; Cullen BR
    Genes Dev; 1992 Nov; 6(11):2077-87. PubMed ID: 1427073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of heterologous downstream sequences on the activity of the HIV-1 promoter and its response to Tat.
    Greenberg ME; Mathews MB
    Nucleic Acids Res; 1997 Dec; 25(24):5017-24. PubMed ID: 9396810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional activity of the human immunodeficiency virus-1 LTR promoter in fission yeast Schizosaccharomyces pombe.
    Toyama R; Bende SM; Dhar R
    Nucleic Acids Res; 1992 May; 20(10):2591-6. PubMed ID: 1598218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that a sequence similar to TAR is important for induction of the JC virus late promoter by human immunodeficiency virus type 1 Tat.
    Chowdhury M; Taylor JP; Chang CF; Rappaport J; Khalili K
    J Virol; 1992 Dec; 66(12):7355-61. PubMed ID: 1331525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recruitment of the TATA-binding protein to the HIV-1 promoter is a limiting step for Tat transactivation.
    Majello B; Napolitano G; Lania L
    AIDS; 1998 Oct; 12(15):1957-64. PubMed ID: 9814863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional activation of minimal HIV-1 promoter by ORF-1 protein expressed from the SalI-L fragment of human herpesvirus 6.
    Kashanchi F; Thompson J; Sadaie MR; Doniger J; Duvall J; Brady JN; Rosenthal LJ
    Virology; 1994 May; 201(1):95-106. PubMed ID: 8178493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Jembrana disease virus Tat can regulate human immunodeficiency virus (HIV) long terminal repeat-directed gene expression and can substitute for HIV Tat in viral replication.
    Chen H; He J; Fong S; Wilcox G; Wood C
    J Virol; 2000 Mar; 74(6):2703-13. PubMed ID: 10684286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.